March 23, 2026 Key takeaways GLP-1 raises resting heart rate and lowers nighttime HRV
Improvements in blood glucose control The clinical trials have shown that retatrutide treatment can lead to significant improvements in glycemic control, as evidenced by reductions in glycated haemoglobin (HbA1c) levels
The validated path comes first: sleep hygiene, cognitive behavioral therapy for insomnia (CBT-I), evaluation for an underlying sleep disorder, and established interventions such as melatonin where appropriate
TrimRX offers a tailored solution to help manage side effects, such as nausea, that can come with GLP-1 receptor agonist medications
doi.org/10.1038/288715a0 Pickart, L., & Margolina, A
And though more than 40% of Americans under 65 with private insurance are likely eligible for GLP-1 medications, only about 12% of adults are currently taking one